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Vaccination Trends and Concerns 
in the SBFP Sub-population
2: Problem Identification
 In 2014 and 2015 the Vermont Department of Health reported that ‘the vast majority of Vermonters 
are immunized’ yet ‘a small numbers of adults and children’ remain. 
 The 2013 Vermont Immunization Program Annual Report indicated that Vermont was below national and state goals in 
toddler immunization (63% Vermont, 68% nat. average, 80% 2020 Healthy People Goal), was average in teen vaccination, 
and was above state average in zoster vaccination and male HPV vaccination. Data regarding PPSV23 immunization was not 
included.
 A 2015 survey of naturopathic providers in Vermont indicated that a substantial portion of their 
patient population feels they have specific concerns and fears around vaccinations that have not been 
adequately heard or addressed by other providers which lead them to choose not to vaccinate or to 
pursue alternative vaccination schedules. 
 This suggests there are likely sub-populations of interest which are not adequately represented by aggregate vaccination 
data, who may be good targets for target discussion and distribution of specific vaccination information material.
 According to the WHO the incidence of measles, mumps, and pertussis in the United States grew 
from 43, 800, and 10,454 in 2007 to 667, 1,223, and 32,971 in 2014 respectively.
 In 2015 Vermont eliminated the philosophical exemption, purchased $13 million in pediatric 
vaccines for use in primary care offices, expanded the HPV Vaccine Initiative group to provide HPV 
vaccinations, and drove the “It’s OK to Ask” campaign to encourage vaccination discourse.  
Unprecedented levels of state support and public awareness make it an opportune time to identify 
and eliminate barriers to vaccination at the community level through primary care provider offices.
3: Public Health Cost
 HealthyPeople.gov and the CDC rank 
vaccines as among the most cost-effective 
preventative health service.
 The Office of Disease Prevention and 
Healthy Promotion estimates that 
vaccination of each yearly birth cohort to 
CDC recommendations reduces health 
care costs by $9.9 billion and saves $33.4 
billion in indirect costs.
 The CDC estimates the per cost of each of 
the most common vaccine preventable 
illness hospitalizations to be as shown in 
table 1.  
 In 2013 there were 9/100,000 cases of pertussis 
in the United States, the highest since the 1950’s.
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What are the most important influences on patient decisions to vaccinate
Towards not vaccinating:
• Cost
• Personal experience with adverse effects 
• Trust/distrust of “Big Pharma”
Toward vaccinating: 
• Provider recommendation
• Trust/Distrust of government recommendations
• Cultural Background
Provider recommendation 
Personal experience with adverse effects 
Trust/Distrust of “Big Pharma”
Cultural background
Are you able to fully address these concerns during OV’s?
Generally. Most difficult: “I don’t know about additives in 
different vaccines.”
Some, although some are accurate (Rotavirus).
What percent of your patients would you say are fully/partially vaccinated?
51-75% (fully)
76+% (at least partially) 
76+% (both)
5: Intervention and Methodology
1. Goal
1. To analyze compliance with CDC vaccination guidelines in order 
to identify vaccinations of concern to patients served by the South 
Burlington FM practice and help address specific issues related to 
those vaccinations.
2. Methodology
1. Over 4 weeks vaccination compliance with CDC guidelines for 
MMR, Tetanus, Diptheria, Pertussis, Influenza, pneumonia 
(PPSV23/13)*, HPV, and Zoster* was assessed at each annual 
physical. No identifying data was recorded.         *when indicated
3. Intervention
1. Develop prepared reference material to which can be included as 
an after-visit summary smart-phrase and/or waiting area 
pamphlet which helps address the most common patient 
concerns.
6a: Results/Response
1. 43 annual wellness visits/physicals between July 
18 and Aug 9 were assessed. 2 were excluded from 
analysis based on pending immunization history.
 30/41 (73.1%) were fully vaccinated to CDC 
recommendations.
 11 (26.8%) did not meet CDC recommendations.
 4 visits were adults >40 years of age, who did not meet Tetanus 
and Pertussis vaccination recommendations.
 2 visits were cases that did not meet PPSV23 vaccination 
recommendations.
 5 visits were cases that did not meet Zoster vaccination 
recommendations.
6b: Results/Response: Zoster Vaccination
 Retrospective meta-review of all patients seen at SBFP in the 
previous 30 days was performed in using bulk queries in Epic 
EMR to review Zoster vaccination statistics. No individual 
identifying data was stored or used for analysis.
 438/1006 (43.5%) patients >60yo did not meet zoster vaccination standards.
 105/289 (36.3%) patients between 60-64yo and eligible for free Zoster coverage 
did not meet recommendations.
 73/228 patients between 61-64yo had had a previous annual visit and did not 
meet recommendations, indicating they did not vaccinate at age 60.
 Compared to the state average of ~47% Shingles vaccination, 
these data suggest that compliance amongst the SBFP clinic is 
quite good. However, a substantial portion of patients who 
would benefit from the vaccine remain unvaccinated despite no 
cost. 
7: Effectiveness and Limitations
1. Effectiveness
1. Assessing the effectiveness of this project can be done by repeating re-
querying the data for vaccination rates at 1 year intervals while keeping the 
sample set and comparing it against both the data here, and against a new 
incoming one.
2. Limitations
1. Improving vaccination rates by addressing patient fears and concerns is 
critical to the continued improvement of community health at the population 
level. While it is fortunate that there is a very high degree of vaccination 
compliance at SBFM, it suggests that demographics choosing not to vaccinate 
or to vaccinate incompletely may not be well represented at SBFM. Engaging 
this population may require an approach outside the scope of the family 
medicine primary care office setting.
2. This study was also limited by the scope of aggregate data access available 
through Epic. Only patients in the last 30 days were able to used in the 
dataset, and the scripting with which to analyze and sort information in the 
dataset was limited to basic queries and filters.
8: Future Follow-up
1. Adults between the 60-64 years of age at SBFP are not limited from 
vaccination by a cost barrier. In addition, provider interviews at SBFP and 
in a 2015 study regarding Naturopathic providers both suggest that the most 
important factor on patient decisions to vaccinate are provider opinions and 
influence. Direct interviews with this population are not possible at the 
moment due to IRB approval requirements, but would be helpful towards 
identifying additional barriers to vaccination in the future.
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